View in EDS HTML Full Text PDF Full Text

Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer.
Authors: Lee W; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA., Wong WB; Genentech Inc., South San Francisco, CA, USA., Kowal S; Genentech Inc., South San Francisco, CA, USA., Garrison LP Jr; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA., Veenstra DL; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA., Li M; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. mli14@mdanderson.org.
Source: PharmacoEconomics [Pharmacoeconomics] 2022 Jun; Vol. 40 (6), pp. 623-631. Date of Electronic Publication: 2022 May 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35527331
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+W%22">Lee W</searchLink>; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Wong+WB%22">Wong WB</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kowal+S%22">Kowal S</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Garrison+LP+Jr%22">Garrison LP Jr</searchLink>; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Veenstra+DL%22">Veenstra DL</searchLink>; The CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. mli14@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2022 Jun; Vol. 40 (6), pp. 623-631. <i>Date of Electronic Publication: </i>2022 May 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35527331
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40273-022-01147-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 623
    Titles:
      – TitleFull: Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee W
      – PersonEntity:
          Name:
            NameFull: Wong WB
      – PersonEntity:
          Name:
            NameFull: Kowal S
      – PersonEntity:
          Name:
            NameFull: Garrison LP Jr
      – PersonEntity:
          Name:
            NameFull: Veenstra DL
      – PersonEntity:
          Name:
            NameFull: Li M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2022 Jun
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2027
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: PharmacoEconomics
              Type: main
ResultId 1